Glimstic MP2

Glimstic MP2 Tablet is a bi-layered formulation designed to provide comprehensive glycemic control in patients with type 2 diabetes mellitus (T2DM). It combines three well-established antidiabetic agents: Glimepiride (2mg), Metformin Hydrochloride (500mg), and Pioglitazone (15mg), each playing a crucial role in lowering blood glucose levels and improving insulin sensitivity.

Managing diabetes requires a multi-targeted approach, and Glimstic MP2 effectively addresses insulin resistance, glucose production, and insulin secretion deficiencies, helping to prevent long-term complications associated with diabetes.

Mechanism of Action:

✔ Glimepiride (2mg): A sulfonylurea that enhances pancreatic beta-cell activity, leading to increased insulin secretion and effective blood glucose reduction.
✔ Metformin Hydrochloride (500mg): A biguanide that reduces hepatic glucose production, improves insulin sensitivity, and enhances glucose uptake by muscle cells.
✔ Pioglitazone (15mg): A thiazolidinedione that reduces insulin resistance, allowing the body to utilize insulin more efficiently and maintain balanced glucose levels.

Possible side effects include hypoglycemia, nausea, dizziness, weight gain, fluid retention, mild gastrointestinal discomfort, and liver enzyme elevation. Seek medical attention if symptoms persist.

Used in the treatment of type 2 diabetes mellitus (T2DM) in adults who require combination therapy to achieve optimal glycemic control.

This medication should be taken under medical supervision. Regular blood sugar monitoring is essential to avoid hypoglycemia or hyperglycemia. Follow a healthy diet and exercise plan for the best therapeutic results.

Store in a cool, dry place, away from direct heat and moisture. Keep out of reach of children